KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Guardant Health (GH) Other Operating Expenses (2017 - 2025)

Historic Other Operating Expenses for Guardant Health (GH) over the last 9 years, with Q3 2025 value amounting to $221.0 million.

  • Guardant Health's Other Operating Expenses rose 2819.13% to $221.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $783.2 million, marking a year-over-year increase of 1229.21%. This contributed to the annual value of $654.7 million for FY2024, which is 809.92% up from last year.
  • Per Guardant Health's latest filing, its Other Operating Expenses stood at $221.0 million for Q3 2025, which was up 2819.13% from $200.8 million recorded in Q2 2025.
  • In the past 5 years, Guardant Health's Other Operating Expenses registered a high of $225.0 million during Q4 2023, and its lowest value of $63.1 million during Q1 2021.
  • Over the past 5 years, Guardant Health's median Other Operating Expenses value was $128.5 million (recorded in 2022), while the average stood at $138.5 million.
  • In the last 5 years, Guardant Health's Other Operating Expenses soared by 7510.91% in 2021 and then plummeted by 1896.87% in 2024.
  • Over the past 5 years, Guardant Health's Other Operating Expenses (Quarter) stood at $93.0 million in 2021, then surged by 38.19% to $128.5 million in 2022, then skyrocketed by 75.07% to $225.0 million in 2023, then decreased by 18.97% to $182.4 million in 2024, then increased by 21.17% to $221.0 million in 2025.
  • Its Other Operating Expenses stands at $221.0 million for Q3 2025, versus $200.8 million for Q2 2025 and $179.0 million for Q1 2025.